大博医疗最新公告：前三季度净利润同比增长77.03%

Core Viewpoint - The company reported significant revenue and profit growth in the third quarter of 2025, indicating strong operational performance and improved financial conditions [1] Financial Performance - The company's revenue for the third quarter reached 666 million yuan, representing a year-on-year increase of 17.82% [1] - The net profit attributable to shareholders for the third quarter was 180 million yuan, showing a substantial year-on-year growth of 77.49% [1] - For the first three quarters, the total revenue amounted to 1.876 billion yuan, reflecting a year-on-year growth of 22.69% [1] - The net profit attributable to shareholders for the first three quarters was 425 million yuan, with a year-on-year increase of 77.03% [1] Growth Drivers - The growth in performance is primarily attributed to an increase in operating income and a decrease in financial expenses due to rising exchange gains [1]